These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 28164488)

  • 41. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
    Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
    Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Mo D; He F
    Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.
    Leuzzi G; Galeone C; Gisabella M; Duranti L; Taverna F; Suatoni P; Morelli D; Pastorino U
    Tumori; 2016 Oct; 102(5):441-449. PubMed ID: 27292573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
    Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
    PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation.
    Thorin-Trescases N; Thorin E
    Oxid Med Cell Longev; 2017; 2017():1096385. PubMed ID: 29138671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer: A meta-analysis.
    Xu Y; Zhang Y; Wang Z; Chen N; Zhou J; Liu L
    Medicine (Baltimore); 2017 Sep; 96(37):e8063. PubMed ID: 28906403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ANGPTL2　- A New Causal Player in Accelerating Heart Disease Development in the Aging.
    Oike Y; Tian Z; Miyata K; Morinaga J; Endo M; Kadomatsu T
    Circ J; 2017 Sep; 81(10):1379-1385. PubMed ID: 28867689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical perspectives on serum tumor marker use in predicting prognosis and treatment response in advanced non-small cell lung cancer.
    Buma AIG; Schuurbiers MMF; van Rossum HH; van den Heuvel MM
    Tumour Biol; 2024; 46(s1):S207-S217. PubMed ID: 36710691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer - significance and development.
    Cascone R; Carlucci A; Pierdiluca M; Santini M; Fiorelli A
    Lung Cancer (Auckl); 2017; 8():161-167. PubMed ID: 29066938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
    Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
    Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic indicators in stage I non-small cell lung cancer].
    Barlési F; Doddoli C; Greillier L; Astoul P; Giudicelli R; Fuentes P; Thomas P
    Rev Mal Respir; 2004 Feb; 21(1):93-103. PubMed ID: 15260042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
    Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
    Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors confounding evaluation of treatment effect in lung cancer.
    Osterlind K
    Lung Cancer; 1994 Mar; 10 Suppl 1():S97-103. PubMed ID: 8087532
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.